<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902458</url>
  </required_header>
  <id_info>
    <org_study_id>P/2014/217</org_study_id>
    <nct_id>NCT02902458</nct_id>
  </id_info>
  <brief_title>Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study</brief_title>
  <acronym>PEACE</acronym>
  <official_title>Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate whether follow-up with a psychologist has an impact on the
      outcome of patients with an implantable automated defibrillator.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The implantation of an ICD in primary prevention is known to increase the rates of anxiety
      and depression, which can reach up to 45% and 35% respectively in this patient population.
      Several studies have reported that psychological accompaniment for these patients can
      alleviate the symptoms of anxiety and/or depression. Therefore, we aim to investigate the
      utility of psychological follow-up for a period of 1 year after first implantation of an ICD
      for primary prevention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>48 hours after implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>2 weeks after implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>2 months after implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>4 months after implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>6 months after implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview score</measure>
    <time_frame>12 months after implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>48 hours after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 weeks after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 months after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 months after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months after implantation</time_frame>
    <description>Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>48 hours after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>2 weeks after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>2 months after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>4 months after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>6 months after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>12 months after implantation</time_frame>
    <description>Measure of state and trait anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>48 hours after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>2 weeks after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>2 months after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>4 months after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>6 months after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>12 months after implantation</time_frame>
    <description>Evaluation of the quality of life in patients with heart failure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Implantable Defibrillator User</condition>
  <arm_group>
    <arm_group_label>Psychological follow-up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing implantation of an ICD for primary prevention will have an individual interview with a qualified psychologist in addition to standard medical follow-up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients undergoing implantation of an ICD for primary prevention will have standard medical follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individual interview with a qualified psychologist</intervention_name>
    <description>Individual, recorded interview with a qualified psychologist to discuss any and all subjects related to the ICD implantation, or any other topics deemed relevant by the patient.</description>
    <arm_group_label>Psychological follow-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients (aged 18 years or over)

          -  indication for implantation of an ICD for primary prophylaxis

          -  written informed consent provided

          -  patients with social security coverage

        Exclusion Criteria:

          -  patients under legal tutorship or guardianship

          -  patients with no social security coverage

          -  patients still within the exclusion period after participation in another clinical
             trial, as indicated by the national registry of clinical trial volunteers

          -  patients unable to complete the questionnaires (language barriers, mentally deficient,
             illiteracy or dementia)

          -  patients awaiting heart transplant

          -  patients who refuse to provide written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Guignier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Besancon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Besancon</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2016</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>implantable cardioverter defibrillator</keyword>
  <keyword>primary prevention</keyword>
  <keyword>psychological follow-up</keyword>
  <keyword>anxiety</keyword>
  <keyword>depression</keyword>
  <keyword>quality of life</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

